"extensive structure" is correct and can be used in written English.
You can use it when describing a complex or detailed arrangement of something, such as a building, organization, or system. It implies that there are many components or elements involved. Example: The extensive structure of the multinational corporation allows for efficient coordination and communication between its numerous departments located in different countries.
It is possible for companies with extensive structure to reduce it.
The Assembly, Council, and Secretariat were the central organs of an extensive structure of auxiliary institutions.
But he sees no reason to apologise for his movement's church-like features, or for the fact that he is hoping to building an extensive structure.
Shops, merchant carts and, of course, an endless stream of bus passengers, are stuffed into every corner of the extensive structure.
Extensive structure activity relationship studies ultimately led to identification of pyrazolodiazepinone, 22, which was >1000-fold >1000-foldfor PDE2 over recombinant, full length PDEselective 3B, 4A, 4B, 4C, 7A, 7B, 8A, 8B, 9, 10 and 11.
For example, a typical realist about length measurement would argue that the empirical regularities displayed by individual objects' lengths when they are ordered and concatenated are best explained by assuming that length is an objective property that has an extensive structure (Swoyer 1987: 271 4).
On the basis of a 4-fold substituted ethylenediamine scaffold, the inhibitors are structurally simple and readily derivatized, facilitating the extensive structure-activity relationship (SAR) study reported herein.
Extensive structure-based computational studies suggested a binding mode for these compounds that led to a structure activity relationship study.
The PNP is an attractive target for drug design and it has been submitted to extensive structure-based design.
Cruzain is the major cysteine protease of T. cruzi and has been the target of extensive structure-based drug design.
COMT is therefore a target for inhibitor development aiming at PD treatment and has been submitted to extensive structure-based drug design.
